BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27077807)

  • 1. Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β.
    Yoon N; Park MS; Shigemoto T; Peltier G; Lee RH
    Cell Death Dis; 2016 Apr; 7(4):e2191. PubMed ID: 27077807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-activated human mesenchymal stromal cells in combination with doxorubicin synergistically enhance tumor-suppressive activity in mice.
    Yoon N; Park MS; Peltier GC; Lee RH
    Cytotherapy; 2015 Oct; 17(10):1332-41. PubMed ID: 26227206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preactivation of human MSCs with TNF-α enhances tumor-suppressive activity.
    Lee RH; Yoon N; Reneau JC; Prockop DJ
    Cell Stem Cell; 2012 Dec; 11(6):825-35. PubMed ID: 23142520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy between RA and TLR3 promotes type I IFN-dependent apoptosis through upregulation of TRAIL pathway in breast cancer cells.
    Bernardo AR; Cosgaya JM; Aranda A; Jiménez-Lara AM
    Cell Death Dis; 2013 Jan; 4(1):e479. PubMed ID: 23370279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of spontaneous breast cancer metastasis by TRAIL-expressing CD34⁺ cells in a xenograft model.
    Rossini A; Giussani M; Giacomini A; Guarnotta C; Tagliabue E; Balsari A
    Breast Cancer Res Treat; 2012 Nov; 136(2):457-67. PubMed ID: 23053664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Claudin-7 suppresses the cytotoxicity of TRAIL-expressing mesenchymal stem cells in H460 human non-small cell lung cancer cells.
    Xia P; Wang W; Bai Y
    Apoptosis; 2014 Mar; 19(3):491-505. PubMed ID: 24242915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells.
    Yoshida T; Zhang Y; Rivera Rosado LA; Zhang B
    Mol Cancer Res; 2009 Nov; 7(11):1835-44. PubMed ID: 19843632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
    Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
    Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
    Wang Y; He L; He G; Kong Y; Liu X; Cai H; Liu X; Tan W
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun; 26(6):780-8. PubMed ID: 20815258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic triterpenoids cooperate with tumor necrosis factor-related apoptosis-inducing ligand to induce apoptosis of breast cancer cells.
    Hyer ML; Croxton R; Krajewska M; Krajewski S; Kress CL; Lu M; Suh N; Sporn MB; Cryns VL; Zapata JM; Reed JC
    Cancer Res; 2005 Jun; 65(11):4799-808. PubMed ID: 15930300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
    Bockbrader KM; Tan M; Sun Y
    Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
    Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
    Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A therapeutic strategy for metastatic malignant fibrous histiocytoma through mesenchymal stromal cell-mediated TRAIL production.
    Lee HJ; Yang HM; Choi YS; Park SH; Moon SH; Lee YS; Sung YC; Kim SJ
    Ann Surg; 2013 May; 257(5):952-60. PubMed ID: 23108118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and TRAIL and suppress the growth of H460 human lung cancer cells.
    Jung PY; Ryu H; Rhee KJ; Hwang S; Lee CG; Gwon SY; Kim J; Kim J; Yoo BS; Baik SK; Bae KS; Eom YW
    Cancer Lett; 2019 Jan; 440-441():202-210. PubMed ID: 30393160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand.
    Du J; Zhou L; Chen X; Yan S; Ke M; Lu X; Wang Z; Yu W; Xiang AP
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1305-14. PubMed ID: 22554587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis.
    Rachner TD; Benad P; Rauner M; Goettsch C; Singh SK; Schoppet M; Hofbauer LC
    J Cell Biochem; 2009 Sep; 108(1):106-16. PubMed ID: 19544400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.
    Yi BR; Hwang KA; Aboody KS; Jeung EB; Kim SU; Choi KC
    Stem Cell Res; 2014 Jan; 12(1):36-48. PubMed ID: 24141111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of MCL1 function sensitizes the MDA-MB-231 breast cancer cells to rh-TRAIL by increasing DR4 levels.
    De Blasio A; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Tesoriere G; Scerri C; Vento R; Di Fiore R
    J Cell Physiol; 2019 Aug; 234(10):18432-18447. PubMed ID: 30912136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pIL6-TRAIL-engineered umbilical cord mesenchymal/stromal stem cells are highly cytotoxic for myeloma cells both in vitro and in vivo.
    Cafforio P; Viggiano L; Mannavola F; Pellè E; Caporusso C; Maiorano E; Felici C; Silvestris F
    Stem Cell Res Ther; 2017 Sep; 8(1):206. PubMed ID: 28962646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.